PREVENTX Revenue and Competitors

Sheffield,

Location

N/A

Total Funding

Health

Industry

Estimated Revenue & Valuation

  • PREVENTX's estimated annual revenue is currently $25.9M per year.(i)
  • PREVENTX's estimated revenue per employee is $316,098

Employee Data

  • PREVENTX has 82 Employees.(i)
  • PREVENTX grew their employee count by 4% last year.

PREVENTX's People

NameTitleEmail/Phone
1
Senior Product OwnerReveal Email/Phone
2
CEOReveal Email/Phone
3
Head Digital MarketingReveal Email/Phone
4
US Country DirectorReveal Email/Phone
5
Group Finance DirectorReveal Email/Phone
6
Group Human Resources Director - GlobalReveal Email/Phone
7
Laboratory DirectorReveal Email/Phone
8
Chief Commercial OfficerReveal Email/Phone
9
Operations ManagerReveal Email/Phone
10
Agile Transformation Programme ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$354.2M89416%N/AN/A
#2
$4.5M24-14%N/AN/A
#3
$25.9M96-14%N/AN/A
#4
$18M50-18%N/AN/A
#5
$10.8M4510%N/AN/A
#6
$32.9M1054%N/AN/A
#7
$187.3M53717%N/AN/A
#8
$417.7M110522%N/AN/A
#9
$25.9M9628%N/AN/A
#10
$108.7M30214%N/AN/A
Add Company

What Is PREVENTX?

Preventx provides integrated testing services to make sexual health screening easier, more accessible and cost effective. Preventx partners with the NHS to screen young people in over 150 local authorities via www.freetest.me, with circa 90,000 tests being completed per annum. Preventx also offers discreet private postal laboratory sexual health tests via www.test.me.

keywords:N/A

N/A

Total Funding

82

Number of Employees

$25.9M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

PREVENTX News

2022-03-30 - Sheffield sexual health test provider Preventx passes four million ...

Preventx partners with over 60 NHS trusts and local authorities, supporting them to deliver care to their communities around the country.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$37.6M85-4%N/A
#2
$7.5M89-5%N/A
#3
$21.3M8914%N/A
#4
$15M89N/AN/A
#5
$14.7M9211%N/A